Author:
Kim Kihyun,Min Chang-Ki,Koh Youngil,Ishizawa Kenichi,Kim Sung-Hyun,Ito Shigeki,Tanaka Junji,Uchiyama Michihiro,Kawano Yawara,Kim Jin Seok,Moreau Philippe,Martin Thomas,Dong Yvonne,Risse Marie-Laure,Suzuki Kenshi
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Kazandjian D. Multiple myeloma epidemiology and survival: a unique malignancy. Semin Oncol. 2016;43(6):676–81.
2. Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328–46.
3. Kang SH, Kim TY, Kim HY, Yoon JH, Cho HI, Yoon SS, et al. Protective role of CYP1A1*2A in the development of multiple myeloma. Acta Haematol. 2008;119(1):60–4.
4. Khuhaprema T, Attasara P, Sriplung H, Wiangnon S, Sangrajrang S. Cancer in Thailand, vol. 7. Thailand: Bangkok Ministry of Public Health and Ministry of Education; 2013.
5. Lee JH, Lee DS, Lee JJ, Chang YH, Jin JY, Jo DY, et al. Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party. Int J Hematol. 2010; 92(1):52–7.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献